1. Value Evidence and Outcomes, Global Medical R&D, GlaxoSmithKline, Uxbridge, United Kingdom
2. Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama
3. COPD Foundation, Miami, Florida
4. University of Nebraska, Omaha, Nebraska
5. BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
6. Boehringer Ingelheim International GmbH, Ingelheim, Germany
7. Chiesi Farmaceutici S.p.A., Parma, Italy
8. Division of Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; and
9. Value Evidence and Outcomes, Medical Innovation, Global Medical R&D, GlaxoSmithKline, Collegeville, Pennsylvania